Related references
Note: Only part of the references are listed.Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
Elizabeth R. Rayburn et al.
DRUG DISCOVERY TODAY (2008)
Overcoming the innate immune response to small interfering RNA
Adam Judge et al.
HUMAN GENE THERAPY (2008)
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
Natee Jearawiriyapaisarn et al.
MOLECULAR THERAPY (2008)
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Mark E. Kleinman et al.
NATURE (2008)
The art and design of genetic screens: RNA interference
Michael Boutros et al.
NATURE REVIEWS GENETICS (2008)
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Maria Frank-Kamenetsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Interfering with disease: a progress report on siRNA-based therapeutics
Antonin de Fougerolles et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Strategies for silencing human disease using RNA interference
Daniel H. Kim et al.
NATURE REVIEWS GENETICS (2007)
Widespread siRNA off-target'' transcript silencing mediated by seed region sequence complementarity
Aimee L. Jackson et al.
RNA (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
DV Morrissey et al.
NATURE BIOTECHNOLOGY (2005)
Toxicology of antisense therapeutics
TLH Jason et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Share Paper
